Stockwatch: Is Mallinckrodt Deep Value Pharma?
Litigation, Depressed Sales and Bankruptcy Warning Place Stock In Value Investing Territory
The pandemic has affected generic pharmaceutical companies more than their branded brethren but accident-prone Mallinckrodt has been hit harder than most.
